ADAM17's involvement in the progression of brain disease is considered a double-edged sword due to its two distinct functions: (1) the regulation of amyloid precursor protein (APP), which is fundamental to preventing the amyloid formation in AD, and (2) the promotion of neuroinflammation, which is also linked to critical mechanisms driving AD progression. Here, ADAM17 is linked to Alzheimer disease.